Actonel Resources
S&C Related Contents
>> Actonel
Osteonecrosis of the Jaw (ONJ)
Osteonecrosis of the Jaw or Dead Jaw
The popular Osteoporosis drug Actonel used by millions of Americans has been linked to Osteonecrosis of the Jaw (ONJ) or "dead jaw."
If you or a loved one have taken Actonel and developed a serious side effect like ONJ, you should contact us immediately. You may be entitled to compensation and we can help.
Actonel, Fosamax, Boniva, Zometa, and Aredia are all in a class of drugs called bisphosphonates and are commonly marketed as medications to help and prevent or treat bone loss in osteoporosis.
There are over 36 million women who use medications like Actonel to prevent or slow osteoporosis. Since the indication of hormone replacement therapy causing increased risk of heart disease and breast cancer, more women are taking bisphosphonates at an earlier age.
Unfortunately with women taking these drugs at an earlier age and for much longer time spans, they are at an increased risk of developing Osteonecrosis of the Jaw (ONJ).
There have been over 2,400 Fosamax (same class of drugs) patients since 2001 that have reported bone death and jaw bone decay or Osteonecrosis of the Jaw.
In addition, more than 120 patients have suffered from such severe pain and debilitation that they have become bedridden or in need of devices like crutches, walkers and wheelchairs.
The typical signs and symptoms of osteonecrosis of the jaw may include pain, swelling or infection of the gums, loosening of the teeth, poor healing of the gums, numbness or a feeling of heaviness in the jaw, drainage and exposed bone. Patients with the least serious form of this condition may not show any symptoms, but in the most serious cases, some patients may require the removal of sections of the jaw.
The Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Actonel lawsuits. We are handling individual litigation nationwide and currently accepting new Actonel cases in all 50 states.
Attention Attorneys: We do not publish prior verdict/settlements. If you are an attorney and would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please visit the attorney referral section of our website.
Free Confidential Case Evaluation
Toll Free 24 hrs/day (866) 588-0600
Secure 128-bit SSL Encrypted Email Communication - Click Here.
Secure 1024-bit SSL Encrypted Live Chat Communication - Click Here.
= Required Field
| Drugs and Treatments - Actonel Oral - WebMD Selected from data included with permission and copyrighted by First DataBank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use ... P&G To Webcast Presentation From the 2008 Goldman Sachs Consumer ... - Forbes CINCINNATI, May 8, 2008 /PRNewswire-FirstCall/ -- Clayton C. Daley, Jr., vice chair and chief financial officer of The Procter & Gamble Company (NYSE: PG) will be a featured speaker at the 2008 Goldman Sachs Consumer Product Symposium in New York ... P&G turns the Tide on liquid laundry - Market-leader encourages ... - CNW Group TORONTO, May 9 /CNW/ - More than 60 years ago, Procter and Gamble established itself as an innovator, revolutionizing fabric care with the introduction of Tide, which became the best-selling laundry detergent within weeks. Starting this month, P&G ... FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal ... - PR Newswire CINCINNATI and BRIDGEWATER, N.J., April 24 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) approved a new once-a-month dose (150 mg) of Actonel(R) (risedronate sodium) tablets for the treatment and prevention of postmenopausal ... Zestra Laboratories Elects New Board of Directors - Forbes Zestra Laboratories, Inc., global innovator in clinically proven intimacy products for women's sexual health, announces the election of four new members to its board of directors, bringing the current number of board members to five. Its flagship ... Procter & Gamble gets approval for new Actonel dose - CNBC CINCINNATI (AP) - Consumer products company Procter & Gamble Co. said Thursday the Food and Drug Administration approved a once-a-month version of its osteoporosis drug Actonel. Osteoporosis is a condition that causes weak bones that are more likely ... Search: All Articles Yellow Pages Entertainment Dining Jobs Cars Homes - Cincinnati Enquirer Search: All Articles Yellow Pages Entertainment Dining Jobs Cars Homes Bob Greifeld, chief executive of the NASDAQ OMX Group, spoke Thursday night at Miami University's third Annual Executive Conference on Governance, Risk Management and Reporting ... P&G gets nod for monthly Actonel - Business Courier Mad cow scare leads firm to sue P&G's Iams [Cincinnati] Watchdog targets P&G ads [Cincinnati] P&G closes Frédéric Fekkai deal [Cincinnati] NTI names new board member [East Bay] Ivax Diagnostics to leave Miami facilities for Weston [South Florida ... Exclusive Reports - Business Courier Suits leave Chiquita uncertain New operators polish Lebanon's Golden Lamb's luster, mine its rich history For AK Steel, demand, stock riding high Middletown, Warren County officials take charge to bring better retail to town Charmin bears hit streets ... Fractures common after failed osteoporosis therapy - Chiropractic Economics NEW YORK (Reuters Health) - Women who fail to respond to, or stop taking, their medication to fight the bone-thinning condition osteoporosis are at high risk of suffering a bone fracture, a new study suggests. British researchers found that among ... |